A detailed history of American Assets Inc transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, American Assets Inc holds 55,000 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,000
Holding current value
$0
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

BUY
N/A
55,000 New
55,000 $0

Others Institutions Holding SBTX

About Silverback Therapeutics, Inc.


  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track American Assets Inc Portfolio

Follow American Assets Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Assets Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Assets Inc with notifications on news.